Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H29NO2.ClH |
| Molecular Weight | 327.889 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)NCC(O)COC1=CC=CC=C1C2CCCCC2
InChI
InChIKey=ODWXZMXQBDEIBF-UHFFFAOYSA-N
InChI=1S/C18H29NO2.ClH/c1-14(2)19-12-16(20)13-21-18-11-7-6-10-17(18)15-8-4-3-5-9-15;/h6-7,10-11,14-16,19-20H,3-5,8-9,12-13H2,1-2H3;1H
Exaprolol is a non-selective antagonist at beta-adrenoceptors exerting antiarrhythmic and local anesthetic activity. It inhibits the inotropic and chronotropic responses. Exaprolol liberates histamine from isolated mast cells and decreases the uptake of extracellular histamine. It acts on mast cells due to the direct and indirect ion exchange mechanism resulted in disproportion between histamine and granule liberation.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PET. | 2007-08-31 |
|
| PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage? | 2004 |
|
| Histamine liberation as a result of nonreceptor interaction. | 1990-04 |
|
| Aspects of the cardiovascular pharmacology of exaprolol. | 1984-09 |
|
| Evidence for intracellular histamine liberation in isolated rat mast cells. | 1982-12 |
|
| Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol. | 1976-04 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C012969
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
DTXSID301350522
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
C65610
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110841
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
300000055489
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
59333-90-3
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
65484
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
297939
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY | |||
|
FGT82HNC7L
Created by
admin on Mon Mar 31 18:27:56 GMT 2025 , Edited by admin on Mon Mar 31 18:27:56 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD